Accelerating Antibiotic Drug Development: FDA Goes Beyond GAIN

FDA is sending a message to industry and Congress of its ongoing work to help companies with antibiotic drug development– beyond the requirements of the FDA Safety and Innovation Act.

More from Clinical Trials

More from R&D